Interpace Biosciences, Inc.
IDXG · OTC · USD
$5.52
−0.382 −6.47%todayNot financial advice.
- Open
- 5.52
- Day range
- 5.52 - 5.52
- 52-week range
- 4.03 - 12.00
- Volume
- 261
- Market cap
- 32.57M
- P/E ratio
- 1.25
- EPS
- 26.79
- Dividend yield
- 0.00%
- Beta
- 0.81
Performance
W
−12.69%
1M
−14.45%
3M
−22.28%
6M
−44.82%
YTD
−15.11%
Y
+11.58%
5Y
−87.23%
All
−100.00%
In the news
Oct 15
Interpace Biosciences Expects Q3 Revenue Growth Up to 14% Sequentially
Interpace Biosciences expects third-quarter 2026 revenue to reach up to $10.4 million, signaling accelerating growth after a softer first half.
Earnings
Oct 15
Interpace Biosciences Expects Up to 18% Q3 Revenue Growth
Interpace Biosciences expects third-quarter revenue to reach up to $10.4 million, representing up to 18% year-over-year growth.
Earnings
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/OTC-IDXG" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Interpace Biosciences, Inc. (IDXG) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/OTC-IDXG">IDXG stock price</a> by FreeTheAI Stocks</p>